Shandong Sinoglory Health Total Assets
Shandong Sinoglory Health total assets. Based on the latest financial reports, Shandong Sinoglory Health (603182) holds total assets worth CN¥1.39 Billion CNY (≈ $203.50 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 603182 market cap for the company's overall valuation and market capitalisation.
Total Assets of Shandong Sinoglory Health (2020–2025)
Total assets of Shandong Sinoglory Health from 2020 to 2025. This chart illustrates how Shandong Sinoglory Health's total assets have evolved over time, based on quarterly financial data. See Shandong Sinoglory Health (603182) stock price for real-time trading data and today's change.
Shandong Sinoglory Health - Asset Composition Analysis
Shandong Sinoglory Health Total Assets Breakdown (December 2025)
Shandong Sinoglory Health total assets breakdown as of December 2025. Shandong Sinoglory Health's total assets of CN¥1.39 Billion consist of 40.1% current assets and 59.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 6.8% |
| Accounts Receivable | CN¥96.10 Million | 7.0% |
| Inventory | CN¥247.55 Million | 18.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥101.56 Million | 7.4% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Shandong Sinoglory Health's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 603182 working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Sinoglory Health's current assets represent 40.1% of total assets in 2025, a decrease from 43.6% in 2020.
- Cash Position: Cash and equivalents constituted 6.8% of total assets in 2025, down from 18.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 11.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 18.0% of total assets.
Shandong Sinoglory Health Competitors by Total Assets
Key competitors of Shandong Sinoglory Health based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
The a2 Milk Company Ltd
AU:A2M
|
Australia | AU$1.96 Billion |
|
Lotus Health Group Co
SHG:600186
|
China | CN¥3.86 Billion |
|
Cisarua Mountain Dairy Tbk PT
JK:CMRY
|
Indonesia | Rp9.48 Trillion |
|
Xiamen Kingdomway Group Co
SHE:002626
|
China | CN¥8.38 Billion |
|
Aryzta AG
SW:ARYN
|
Switzerland | CHF1.89 Billion |
|
Jiangsu Hengshun Vinegar-Industry Co Ltd
SHG:600305
|
China | CN¥4.24 Billion |
|
Yan Tai Shuang Ta Food Co Ltd
SHE:002481
|
China | CN¥4.48 Billion |
|
SDIC Zhonglu Fruit Juice Co Ltd
SHG:600962
|
China | CN¥2.23 Billion |
Shandong Sinoglory Health - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.27 | 2.84 | 4.52 |
| Quick Ratio | 1.98 | 1.56 | 3.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥403.29 Million | CN¥326.15 Million | CN¥684.28 Million |
Shandong Sinoglory Health - Advanced Valuation Insights
This section examines the relationship between Shandong Sinoglory Health's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.96 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | -4.0% |
| Total Assets | CN¥1.37 Billion |
| Market Capitalization | $278.83 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Sinoglory Health's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Sinoglory Health's assets decreased by 4.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Sinoglory Health (2020–2025)
The table below shows the annual total assets of Shandong Sinoglory Health from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.37 Billion ≈ $201.18 Million |
-4.00% |
| 2024-12-31 | CN¥1.43 Billion ≈ $209.56 Million |
+11.45% |
| 2023-12-31 | CN¥1.28 Billion ≈ $188.03 Million |
+8.58% |
| 2022-12-31 | CN¥1.18 Billion ≈ $173.18 Million |
+46.91% |
| 2021-12-31 | CN¥805.58 Million ≈ $117.88 Million |
+27.77% |
| 2020-12-31 | CN¥630.51 Million ≈ $92.26 Million |
-- |
About Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd., together with its subsidiaries, produces and sells soybean protein series products under the SINOGLORY brand in China and internationally. The company offers soy protein powder drinks, soybean oil, soy dietary fiber products, soy protein isolates and concentrates, textured soy protein products, and low-temperature edible soybean meals for meat application… Read more